Cancer incidence among seafarers and fishermen in the Nordic countries.


Journal

Scandinavian journal of work, environment & health
ISSN: 1795-990X
Titre abrégé: Scand J Work Environ Health
Pays: Finland
ID NLM: 7511540

Informations de publication

Date de publication:
01 09 2020
Historique:
pubmed: 10 1 2020
medline: 25 3 2021
entrez: 10 1 2020
Statut: ppublish

Résumé

Objectives Maritime workers may be exposed to several occupational hazards at sea. The aim of this study was to assess cancer incidence among seafarers and fishermen in the Nordic countries and identify patterns in morbidity in the context of existing studies in this field. Methods A cohort of 81 740 male seafarers and 66 926 male fishermen was established from census data on 15 million citizens in the five Nordic countries. Using personal identity codes, information on vital status and cancer was linked to members of the cohort from the national population and cancer registries for the follow-up period 1961-2005. Standardized incidence ratios (SIR) were calculated applying national cancer incidence rates for each country and pooling results. Results The overall incidence of cancer was increased among the male seafarers [SIR 1.22, 95% confidence interval (CI) 1.19-1.23]. Significant excesses were observed for multiple cancer sites among the seafarers, while results for the fishermen were mixed. Lip cancer incidence was increased among both maritime populations. For mesothelioma (SIR 2.17, 95% CI 1.83-2.56 seafarers) and non-melanoma skin cancer (SIR 1.23, 95% CI 1.14-1.32 seafarers), incidence was increased among the seafarers. Conclusion In our cohort, seafaring was associated with a higher overall incidence of cancer compared to the general population. While the majority of cancers could not be linked to specific occupational factors, increases in mesothelioma, lip and non-melanoma-skin cancer indicate previous exposure to asbestos, ultraviolet radiation and potentially also chemicals with dermal carcinogenic properties at sea.

Identifiants

pubmed: 31917456
pii: 3879
doi: 10.5271/sjweh.3879
pmc: PMC7737810
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

461-468

Références

Occup Environ Med. 2002 Sep;59(9):613-9
pubmed: 12205234
Scand J Public Health. 2014 Aug;42(6):534-45
pubmed: 24876236
Occup Environ Med. 2005 Nov;62(11):761-5
pubmed: 16234401
Scand J Work Environ Health. 1992 Aug;18(4):217-24
pubmed: 1411363
Acta Oncol. 2010 Jun;49(5):725-36
pubmed: 20491528
N Engl J Med. 1975 Aug 28;293(9):419-24
pubmed: 1152953
Int Marit Health. 2011;62(2):98-103
pubmed: 21910112
Occup Environ Med. 2014 Jun;71(6):398-404
pubmed: 24510539
Occup Environ Med. 2018 Aug;75(8):582-585
pubmed: 29779004
Am J Ind Med. 1997 May;31(5):662-8
pubmed: 9099372
Photochem Photobiol. 2013 Nov-Dec;89(6):1497-506
pubmed: 23875870
Scand J Public Health. 2011 Jul;39(7 Suppl):22-5
pubmed: 21775345
Am J Ind Med. 1995 Feb;27(2):187-93
pubmed: 7755009
Eur J Cancer B Oral Oncol. 1994 May;30B(3):209-15
pubmed: 7920169
Cancer Causes Control. 2014 Dec;25(12):1595-602
pubmed: 25209112
J Occup Environ Hyg. 2005 Nov;2(11):586-99
pubmed: 16234219
Indian J Occup Environ Med. 2009 Aug;13(2):77-9
pubmed: 20386623
Acta Oncol. 2009;48(5):646-790
pubmed: 19925375
J Natl Cancer Inst. 2011 Dec 21;103(24):1827-39
pubmed: 22158127
Int Marit Health. 2017;68(4):203-210
pubmed: 29297571
BMC Public Health. 2019 Jan 9;19(1):45
pubmed: 30626365
Acta Oncol. 2018 Apr;57(4):440-455
pubmed: 29226751
IARC Monogr Eval Carcinog Risks Hum. 2010;92:1-853
pubmed: 21141735
Chemosphere. 2009 Feb;74(7):938-43
pubmed: 19041115
J Occup Health. 2010;52(5):249-56
pubmed: 20661002
Am J Ind Med. 2011 Dec;54(12):971-9
pubmed: 21692095
Clin Nutr Res. 2014 Jul;3(2):75-88
pubmed: 25136535
G Ital Med Lav Ergon. 2013 Oct-Dec;35(4):206-10
pubmed: 24303696

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH